在FDA不良事件报告系统 (FAERS) 数据库中对托波特干与贝瓦齐祖马布或环胺结合的真实数据分析
Huihui Chen1, Guobiao Zhuang1, Shihao Hong2,3,4
1Department of Obstetrics and Gynecology, Ninghai Maternal and Child Health Hospital, Ningbo, China.
Expert opinion on drug safety
|April 2, 2025
概括
这项研究确定了托波特干,贝瓦齐祖马布和环胺的新药不良反应 (ADR),并指出了托波特干敏感性的潜在性别差异.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 药物不良反应 (ADRs) 对于联合癌症治疗的监测至关重要.
- 了解ADR有助于临床医生优化治疗计划和药物选择.
研究的目的:
- 为了检测和量化与托波特干,贝瓦齐祖马布和环胺组合相关的不良反应.
- 为了确定新的药物不良反应和药物反应中的潜在基于性别的差异.
主要方法:
- 利用美国食品和药物管理局的不良事件报告系统 (FAERS) 进行数据分析.
- 采用统计方法,包括报告比率,PRR,BCPN和EBGM来检测不良事件信号.
- 进行了子组分析,以比较单独托波特干的不良事件.
主要成果:
- 鉴定了1,789个与托波特坎相关的首要疑似不良事件 (PS AEs).
- 在不同年龄组的女性中观察到较低的韦布尔形状参数 (β),这表明对托波特坎的不良影响的敏感性更高.
- 检测到既已知的 (例如,中性质减退,贫血) 和新药不良反应.
结论:
- 确认了对托波特干,贝瓦齐祖马布和环胺组合的预期和新发现的副作用.
- 突出了潜在的基于性别的托波特干反应差异,值得进一步调查.
- 强调了联合癌症疗法持续药物监测的重要性.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
04:48Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
7.3K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
